J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 60,000 shares at $85.54 ($5.1M) on 2021-04-22, disclosed to the SEC on 2021-04-26.
Open-market sale of $5.1M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.54 | 30,000 | $2.6M | 50.1% |
| 2 | $85.24 | 30,000 | $2.6M | 49.9% |
| Total | $85.39 avg | 60,000 | $5.1M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |